HD Biosciences Co., Ltd. is a Shanghai based biotech company, specializing in high value drug discovery contract research services. HD Biosciences has developed comprehensive technology platforms and expertise around drug discovery assays/assay development, high throughput drug screening, and hit-to-lead biology, as well as natural product based lead compound discovery.

HD Biosciences was founded in October 2002 with a state-of-the-art facility in Zhangjiang Hi-Tech Park. In the early part of 2007, a new facility was added including high throughput screening bay with a JANUS Workstation, and a new cell culture facility. A fully compliant EHS (environmental, health, and security) system has been implemented to meet the most stringent industry standards and regulations.

HD Biosciences is patterned after an internationalized business model, ensuring strong quality assurance, cost control, and project management. The company's business focuses on cost-effective industry-compliant discovery services for drug discovery and development. The company's mission is to provide advanced solutions for world-class drug discovery and assist pharmaceutical and biotechnology companies in their search for innovative, effective and safe drug candidates at a controlled cost. The company's high quality research services have earned overwhelming recognition among existing clients and within the CRO community.